Literature DB >> 12429093

The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance.

Lars Kjer-Nielsen1, Craig S Clements, Andrew G Brooks, Anthony W Purcell, James McCluskey, Jamie Rossjohn.   

Abstract

Despite a potential repertoire of >10(15) alphabeta T cell receptors (TcR), the HLA B8-restricted cytolytic T cell response to a latent antigen of Epstein-Barr virus (EBV) is strikingly limited in the TcR sequences that are selected. Even in unrelated individuals this response is dominated by a single highly restricted TcR clonotype that selects identical combinations of hypervariable Valpha, Vbeta, D, J, and N region genes. We have determined the 1.5 A crystal structure of this "public" TcR, revealing that five of the six hypervariable loops adopt novel conformations providing a unique combining site that contains a deep pocket predicted to overlay the HLA B8-peptide complex. The findings suggest a structural basis for the immunodominance of this clonotype in the immune response to EBV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429093     DOI: 10.1016/s0969-2126(02)00878-x

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  27 in total

1.  Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.

Authors:  Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

2.  A role for CD8 in the developmental tuning of antigen recognition and CD3 conformational change.

Authors:  Diana Gil; Adam G Schrum; Mark A Daniels; Ed Palmer
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

3.  Many different Vbeta CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions.

Authors:  Kira Rubtsova; James P Scott-Browne; Frances Crawford; Shaodong Dai; Philippa Marrack; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

4.  Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism.

Authors:  Daniel R Scott; Oleg Y Borbulevych; Kurt H Piepenbrink; Steven A Corcelli; Brian M Baker
Journal:  J Mol Biol       Date:  2011-10-12       Impact factor: 5.469

5.  A conserved αβ transmembrane interface forms the core of a compact T-cell receptor-CD3 structure within the membrane.

Authors:  Logesvaran Krshnan; Soohyung Park; Wonpil Im; Melissa J Call; Matthew E Call
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

Review 6.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 7.  A view into the blind spot: solution NMR provides new insights into signal transduction across the lipid bilayer.

Authors:  Matthew E Call; James J Chou
Journal:  Structure       Date:  2010-12-08       Impact factor: 5.006

8.  Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection.

Authors:  Yiyuan Yin; Yili Li; Melissa C Kerzic; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

Review 9.  Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.

Authors:  Kathryn M Armstrong; Kurt H Piepenbrink; Brian M Baker
Journal:  Biochem J       Date:  2008-10-15       Impact factor: 3.857

10.  Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.

Authors:  Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.